Prime Medicine, Inc.
PRME
$3.55
$0.3310.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.75M | 144.26M | 190.44M | 175.53M | 162.87M |
| Total Receivables | 120.00K | 17.00K | -- | 55.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.03M | 2.95M | 6.78M | 6.01M | 4.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.39M | 16.54M | 14.67M | 9.54M | 3.74M |
| Total Current Assets | 121.29M | 163.77M | 211.89M | 246.07M | 170.80M |
|
|
|||||
| Total Current Assets | 121.29M | 163.77M | 211.89M | 246.07M | 170.80M |
| Net Property, Plant & Equipment | 144.03M | 150.34M | 71.56M | 72.65M | 75.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.69M | 14.06M | 14.06M | 14.06M | 13.50M |
| Total Assets | 279.01M | 328.16M | 297.51M | 332.78M | 259.71M |
|
|
|||||
| Total Accounts Payable | 6.38M | 10.03M | 11.35M | 5.43M | 4.64M |
| Total Accrued Expenses | 11.04M | 6.16M | 11.82M | 17.28M | 8.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.26M | 6.86M | 3.61M | 4.48M | 5.22M |
| Total Finance Division Other Current Liabilities | 9.43M | 11.25M | 11.18M | 10.68M | 2.07M |
| Total Other Current Liabilities | 9.43M | 11.25M | 11.18M | 10.68M | 2.07M |
| Total Current Liabilities | 34.11M | 34.29M | 37.96M | 37.88M | 20.75M |
|
|
|||||
| Total Current Liabilities | 34.11M | 34.29M | 37.96M | 37.88M | 20.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 112.48M | 114.29M | 37.18M | 36.76M | 36.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.56M | 72.66M | 69.22M | 68.64M | 6.00M |
| Total Liabilities | 218.15M | 221.24M | 144.36M | 143.28M | 63.12M |
|
|
|||||
| Common Stock & APIC | 852.56M | 846.04M | 840.36M | 834.42M | 789.08M |
| Retained Earnings | -791.69M | -739.10M | -687.21M | -644.94M | -592.42M |
| Treasury Stock & Other | -10.00K | -15.00K | 1.00K | 21.00K | -71.00K |
| Total Common Equity | 60.86M | 106.92M | 153.15M | 189.50M | 196.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.86M | 106.92M | 153.15M | 189.50M | 196.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 60.86M | 106.92M | 153.15M | 189.50M | 196.59M |
|
|
|||||